During the past decade, Takarazuka City Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Takarazuka City Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Takarazuka City Hospital" are "Colorectal Cancer" (2 trials), "Extensive Disease Small Cell Lung Cancer" (1 trials), "Growth Hormone Deficiency" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Non-small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Takarazuka City Hospital" in a lesser frequency.

Most popular intervention types in "Takarazuka City Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "Baricitinib" (1 trials), "Genotropin" (1 trials), "MOD-4023" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Takarazuka City Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Takarazuka City Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Takarazuka City Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Takarazuka City Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".